Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study

REFERENCES

1. 1.↵
   2. Mahad DH,
   3. Trapp BD,
   4. Lassmann H

   . Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 2015;14:183–93 doi:10.1016/S1474-4422(14)70256-X pmid:25772897

   CrossRefPubMed
2. 2.↵
   2. Herranz E,
   3. Gianni C,
   4. Louapre C, et al

   . Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol 2016;80:776–90 doi:10.1002/ana.24791 pmid:27686563

   CrossRefPubMed
3. 3.↵
   2. Magliozzi R,
   3. Howell O,
   4. Vora A, et al

   . Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089–104 pmid:17438020

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Lucchinetti CF,
   3. Popescu BF,
   4. Bunyan RF, et al

   . Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188–97 doi:10.1056/NEJMoa1100648 pmid:22150037

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Haider L,
   3. Zrzavy T,
   4. Hametner S, et al

   . The topography of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 2016;139:807–15 doi:10.1093/brain/awv398 pmid:26912645

   CrossRefPubMed
6. 6.↵
   2. Choi SR,
   3. Howell OW,
   4. Carassiti D, et al

   . Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain 2012;135:2925–37 doi:10.1093/brain/aws189 pmid:22907116

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Howell OW,
   3. Reeves CA,
   4. Nicholas R, et al

   . Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011;134:2755–71 doi:10.1093/brain/awr182 pmid:21840891

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Popescu BF,
   3. Lucchinetti CF

   . Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 2012;12:11 doi:10.1186/1471-2377-12-11 pmid:22397318

   CrossRefPubMed
9. 9.↵
   2. Serafini B,
   3. Rosicarelli B,
   4. Magliozzi R, et al

   . Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004;14:164–74 doi:10.1111/j.1750-3639.2004.tb00049.x pmid:15193029

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Zurawski J,
    3. Lassmann H,
    4. Bakshi R

    . Use of magnetic resonance imaging to visualize leptomeningeal inflammation in patients with multiple sclerosis: a review. JAMA Neurol 2017;74:100–09 doi:10.1001/jamaneurol.2016.4237 pmid:27893883

    CrossRefPubMed
11. 11.↵
    2. Absinta M,
    3. Vuolo L,
    4. Rao A, et al

    . Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology 2015;85:18–28 doi:10.1212/WNL.0000000000001587 pmid:25888557

    Abstract/FREE Full Text
12. 12.↵
    2. Harrison DM,
    3. Wang KY,
    4. Fiol J, et al

    . Leptomeningeal enhancement at 7T in multiple sclerosis: frequency, morphology, and relationship to cortical volume. J Neuroimaging 2017;27:461–68 doi:10.1111/jon.12444 pmid:28464368

    CrossRefPubMed
13. 13.↵
    2. Zivadinov R,
    3. Ramasamy DP,
    4. Hagemeier J, et al

    . Evaluation of leptomeningeal contrast enhancement using pre-and postcontrast subtraction 3D-FLAIR imaging in multiple sclerosis. AJNR Am J Neuroradiol 2018;39:642–47 doi:10.3174/ajnr.A5541 pmid:29439125

    Abstract/FREE Full Text
14. 14.↵
    2. Zivadinov R,
    3. Ramasamy DP,
    4. Vaneckova M, et al

    . Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: a retrospective, pilot, observational longitudinal study. Mult Scler 2017;23:1336–45 doi:10.1177/1352458516678083 pmid:27811339

    CrossRefPubMed
15. 15.↵
    2. Makshakov G,
    3. Magonov E,
    4. Totolyan N, et al

    . Leptomeningeal contrast enhancement is associated with disability progression and grey matter atrophy in multiple sclerosis. Neurol Res Int 2017;2017:8652463 doi:10.1155/2017/8652463 pmid:29291134

    CrossRefPubMed
16. 16.↵
    2. Bö L,
    3. Geurts JG,
    4. van der Valk P, et al

    . Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007;64:76–80 doi:10.1001/archneur.64.1.76 pmid:17210812

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Calabrese M,
    3. Seppi D,
    4. Romualdi C, et al

    . Gray matter pathology in MS: a 3-year longitudinal study in a pediatric population. AJNR Am J Neuroradiol 2012;33:1507–11 doi:10.3174/ajnr.A3011 pmid:22422186

    Abstract/FREE Full Text
18. 18.↵
    2. Kappus N,
    3. Weinstock-Guttman B,
    4. Hagemeier J, et al

    . Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016;87:181–87 doi:10.1136/jnnp-2014-310051 pmid:25722366

    Abstract/FREE Full Text
19. 19.↵
    2. Polman CH,
    3. Reingold SC,
    4. Banwell B, et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Dale AM,
    3. Fischl B,
    4. Sereno MI

    . Cortical surface-based analysis, I: segmentation and surface reconstruction. Neuroimage 1999;9:179–94 doi:10.1006/nimg.1998.0395 pmid:9931268

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Fischl B,
    3. Salat DH,
    4. Busa E, et al

    . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55 doi:10.1016/S0896-6273(02)00569-X pmid:11832223

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Magon S,
    3. Gaetano L,
    4. Chakravarty MM, et al

    . White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study. BMC Neurosci 2014;15:106 doi:10.1186/1471-2202-15-106 pmid:25200127

    CrossRefPubMed
23. 23.↵
    2. Greve DN,
    3. Fischl B

    . Accurate and robust brain image alignment using boundary-based registration. Neuroimage 2009;48:63–72 doi:10.1016/j.neuroimage.2009.06.060 pmid:19573611

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Magliozzi R,
    3. Howell OW,
    4. Reeves C, et al

    . A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010;68:477–93 doi:10.1002/ana.22230 pmid:20976767

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Schläger C,
    3. Körner H,
    4. Krueger M, et al

    . Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature 2016;530:349–53 doi:10.1038/nature16939 pmid:26863192

    CrossRefPubMed
26. 26.↵
    2. Sepulcre J,
    3. Goñi J,
    4. Masdeu JC, et al

    . Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. Arch Neurol 2009;66:173–79 doi:10.1001/archneurol.2008.562 pmid:19204153

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Bergsland N,
    3. Laganà MM,
    4. Tavazzi E, et al

    . Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclerosis. Mult Scler 2015;21:1771–80 doi:10.1177/1352458515576985 pmid:25791368

    CrossRefPubMed
28. 28.↵
    2. Steenwijk MD,
    3. Daams M,
    4. Pouwels PJ, et al

    . Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Hum Brain Mapp 2015;36:1796–807 doi:10.1002/hbm.22738 pmid:25627545

    CrossRefPubMed
29. 29.↵
    2. Jonas SN,
    3. Izbudak I,
    4. Frazier AA, et al

    . Longitudinal persistence of meningeal enhancement on postcontrast 7T 3D-FLAIR MRI in multiple sclerosis. AJNR Am J Neuroradiol 2018;39:1799–805 doi:10.3174/ajnr.A5796 pmid:30213813

    Abstract/FREE Full Text
30. 30.↵
    2. Nielsen AS,
    3. Kinkel RP,
    4. Tinelli E, et al

    . Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson Imaging 2012;35:537–42 doi:10.1002/jmri.22847 pmid:22045554

    CrossRefPubMed
31. 31.↵
    2. Harrison D,
    3. Jonas S,
    4. Izbudak I

    . Investigating the relationship between meningeal enhancement on 7T MRI and cortical gray matter lesions in multiple sclerosis. In: Proceedings of the Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Germany. October 10–12, 2018; 489